Several companies have reported their Q2 earnings for the fiscal year 2025. Syngene International reported a net profit of ₹106.1 crore, slightly above the CNBC-TV18 poll of ₹101 crore, with revenue at ₹891 crore and EBITDA at ₹245 crore. Syngene's net profit declined 9.4% to ₹106 crore versus ₹117 crore in the same period last year. Dr Lal Path Labs posted a net profit of ₹130.8 crore, surpassing the CNBC-TV18 poll of ₹124.7 crore, with revenue at ₹660.2 crore and EBITDA at ₹202.5 crore. Aster DM Healthcare reported a net profit of ₹96.8 crore, a significant turnaround from a loss of ₹30.8 crore YoY, with revenue up 17% to ₹1,086.4 crore and EBITDA up 33.2% to ₹381.4 crore. The company's margin improved to 35% from 30.8% YoY.